Predicting Risk of Lymph Node Metastasis in Neuroendocrine Carcinoma of Cervix: A Validated Nomogram Incorporating Neuroendocrine Markers and Clinical Parameters. | Synapse
March 8, 2026
Predicting Risk of Lymph Node Metastasis in Neuroendocrine Carcinoma of Cervix: A Validated Nomogram Incorporating Neuroendocrine Markers and Clinical Parameters.
Key Points
This research aims to develop a nomogram that combines clinical parameters and neuroendocrine markers to predict lymph node metastasis risk in neuroendocrine carcinoma of the cervix.
Developed a nomogram model based on clinical parameters
Incorporated neuroendocrine markers into the model
Validated the effectiveness of the nomogram in predicting risk
Identified low-risk populations for lymph node metastasis
The nomogram effectively predicts the probability of lymph node metastasis in neuroendocrine carcinoma of the cervix
Successfully identifies low-risk patients for targeted management
Demonstrates improved risk assessment compared to traditional methods
Abstract
The nomogram model constructed by combining clinical parameters with neuroendocrine markers could effectively predict the risk probability of LNM in NECC and identify the low-risk population.